242 related articles for article (PubMed ID: 36868546)
1. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
[TBL] [Abstract][Full Text] [Related]
2. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease.
He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q
Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160
[TBL] [Abstract][Full Text] [Related]
3. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
Liu B; Liu J; Wang JG; Liu CL; Yan HJ
Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
[TBL] [Abstract][Full Text] [Related]
4. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline.
Wang L; Liu M; Gao J; Smith AM; Fujioka H; Liang J; Perry G; Wang X
J Alzheimers Dis; 2021; 84(3):1057-1069. PubMed ID: 34602490
[TBL] [Abstract][Full Text] [Related]
6. AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.
Khandelwal M; Manglani K; Upadhyay P; Azad M; Gupta S
Neurobiol Dis; 2022 Nov; 174():105876. PubMed ID: 36162737
[TBL] [Abstract][Full Text] [Related]
7. Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer's disease mouse model.
Ng RC; Jian M; Ma OK; Bunting M; Kwan JS; Zhou GJ; Senthilkumar K; Iyaswamy A; Chan PK; Li M; Leung KM; Kumar Durairajan SS; Lam KS; Chu LW; Festenstein R; Chung SK; Chan KH
Mol Psychiatry; 2021 Oct; 26(10):5669-5689. PubMed ID: 32132650
[TBL] [Abstract][Full Text] [Related]
8. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
[TBL] [Abstract][Full Text] [Related]
9. Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease.
Sun XY; Li LJ; Dong QX; Zhu J; Huang YR; Hou SJ; Yu XL; Liu RT
J Neuroinflammation; 2021 Jun; 18(1):131. PubMed ID: 34116706
[TBL] [Abstract][Full Text] [Related]
10. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
11. AdipoRon Ameliorates Synaptic Dysfunction and Inhibits tau Hyperphosphorylation through the AdipoR/AMPK/mTOR Pathway in T2DM Mice.
Zhao W; Zhang W; Hu Y; Zhou Y; Zhao J; Li Y; Xu Z
Neurochem Res; 2024 May; ():. PubMed ID: 38819697
[TBL] [Abstract][Full Text] [Related]
12. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of AMPK Ameliorates Alzheimer's Disease-Like Tau Pathology and Memory Impairment.
Wang L; Li N; Shi FX; Xu WQ; Cao Y; Lei Y; Wang JZ; Tian Q; Zhou XW
Mol Neurobiol; 2020 Aug; 57(8):3349-3361. PubMed ID: 32519244
[TBL] [Abstract][Full Text] [Related]
14. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.
Zhang Y; Zhao J; Li R; Lau WB; Yuan YX; Liang B; Li R; Gao EH; Koch WJ; Ma XL; Wang YJ
Am J Physiol Endocrinol Metab; 2015 Aug; 309(3):E275-82. PubMed ID: 26037251
[TBL] [Abstract][Full Text] [Related]
15. Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
Hou TY; Zhou Y; Zhu LS; Wang X; Pang P; Wang DQ; Liuyang ZY; Man H; Lu Y; Zhu LQ; Liu D
J Neurochem; 2020 Aug; 154(4):441-457. PubMed ID: 31951013
[TBL] [Abstract][Full Text] [Related]
16. Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease.
Liu D; Tang H; Li XY; Deng MF; Wei N; Wang X; Zhou YF; Wang DQ; Fu P; Wang JZ; Hébert SS; Chen JG; Lu Y; Zhu LQ
Mol Ther; 2017 Mar; 25(3):752-764. PubMed ID: 28202389
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
18. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
[TBL] [Abstract][Full Text] [Related]
20. Tetrandrine ameliorates cognitive deficits and mitigates tau aggregation in cell and animal models of tauopathies.
Tong BC; Huang AS; Wu AJ; Iyaswamy A; Ho OK; Kong AH; Sreenivasmurthy SG; Zhu Z; Su C; Liu J; Song J; Li M; Cheung KH
J Biomed Sci; 2022 Oct; 29(1):85. PubMed ID: 36273169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
